Northern Trust’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.21M Sell
114,631
-6,184
-5% -$65.4K ﹤0.01% 3286
2025
Q1
$1.82M Sell
120,815
-2,383
-2% -$35.8K ﹤0.01% 2973
2024
Q4
$2.03M Sell
123,198
-112
-0.1% -$1.84K ﹤0.01% 3014
2024
Q3
$3.05M Sell
123,310
-6,627
-5% -$164K ﹤0.01% 2741
2024
Q2
$3.29M Sell
129,937
-4,754
-4% -$120K ﹤0.01% 2626
2024
Q1
$3.42M Sell
134,691
-2,729
-2% -$69.3K ﹤0.01% 2699
2023
Q4
$3.11M Sell
137,420
-9,037
-6% -$205K ﹤0.01% 2749
2023
Q3
$2.73M Sell
146,457
-13,154
-8% -$245K ﹤0.01% 2767
2023
Q2
$4.15M Sell
159,611
-483
-0.3% -$12.5K ﹤0.01% 2598
2023
Q1
$4.6M Buy
160,094
+167
+0.1% +$4.8K ﹤0.01% 2524
2022
Q4
$4.73M Sell
159,927
-7,378
-4% -$218K ﹤0.01% 2522
2022
Q3
$3.98M Sell
167,305
-5,114
-3% -$122K ﹤0.01% 2630
2022
Q2
$3.85M Sell
172,419
-11,962
-6% -$267K ﹤0.01% 2669
2022
Q1
$4.63M Sell
184,381
-24,247
-12% -$609K ﹤0.01% 2622
2021
Q4
$7.48M Sell
208,628
-9,334
-4% -$334K ﹤0.01% 2442
2021
Q3
$9.28M Sell
217,962
-1,240
-0.6% -$52.8K ﹤0.01% 2331
2021
Q2
$9.49M Buy
219,202
+26,118
+14% +$1.13M ﹤0.01% 2402
2021
Q1
$7.88M Sell
193,084
-36,675
-16% -$1.5M ﹤0.01% 2457
2020
Q4
$10.4M Sell
229,759
-9,520
-4% -$431K ﹤0.01% 2223
2020
Q3
$8.47M Sell
239,279
-7,558
-3% -$267K ﹤0.01% 2203
2020
Q2
$9.31M Buy
246,837
+55,540
+29% +$2.1M ﹤0.01% 2139
2020
Q1
$5.53M Sell
191,297
-757
-0.4% -$21.9K ﹤0.01% 2240
2019
Q4
$9.96M Sell
192,054
-3,955
-2% -$205K ﹤0.01% 2182
2019
Q3
$10.8M Sell
196,009
-832
-0.4% -$45.7K ﹤0.01% 2091
2019
Q2
$8M Buy
196,841
+3,542
+2% +$144K ﹤0.01% 2291
2019
Q1
$5.85M Sell
193,299
-307
-0.2% -$9.28K ﹤0.01% 2466
2018
Q4
$6.51M Sell
193,606
-4,200
-2% -$141K ﹤0.01% 2340
2018
Q3
$8.34M Buy
197,806
+459
+0.2% +$19.4K ﹤0.01% 2362
2018
Q2
$6.32M Sell
197,347
-2,075
-1% -$66.4K ﹤0.01% 2556
2018
Q1
$9.92M Buy
199,422
+9
+0% +$447 ﹤0.01% 2175
2017
Q4
$10.8M Buy
199,413
+426
+0.2% +$23K ﹤0.01% 2134
2017
Q3
$11.5M Sell
198,987
-4,273
-2% -$248K ﹤0.01% 2109
2017
Q2
$10M Buy
203,260
+8,189
+4% +$404K ﹤0.01% 2181
2017
Q1
$8.47M Buy
195,071
+7,128
+4% +$310K ﹤0.01% 2228
2016
Q4
$9.2M Buy
187,943
+3,444
+2% +$169K ﹤0.01% 2173
2016
Q3
$8.83M Buy
184,499
+144
+0.1% +$6.89K ﹤0.01% 2160
2016
Q2
$9.89M Sell
184,355
-4,671
-2% -$251K ﹤0.01% 2036
2016
Q1
$8.45M Buy
189,026
+1,768
+0.9% +$79.1K ﹤0.01% 2080
2015
Q4
$7.15M Buy
187,258
+7,240
+4% +$276K ﹤0.01% 2233
2015
Q3
$5.73M Buy
180,018
+99
+0.1% +$3.15K ﹤0.01% 2358
2015
Q2
$5.94M Sell
179,919
-301
-0.2% -$9.94K ﹤0.01% 2416
2015
Q1
$7.42M Buy
180,220
+809
+0.5% +$33.3K ﹤0.01% 2254
2014
Q4
$7.31M Sell
179,411
-4,655
-3% -$190K ﹤0.01% 2252
2014
Q3
$6.75M Buy
184,066
+22,301
+14% +$818K ﹤0.01% 2307
2014
Q2
$7.5M Sell
161,765
-13,460
-8% -$624K ﹤0.01% 2242
2014
Q1
$7.2M Sell
175,225
-7,624
-4% -$313K ﹤0.01% 2330
2013
Q4
$6.98M Buy
182,849
+3,544
+2% +$135K ﹤0.01% 2326
2013
Q3
$4.28M Sell
179,305
-4,767
-3% -$114K ﹤0.01% 2609
2013
Q2
$3.13M Buy
+184,072
New +$3.13M ﹤0.01% 2710